Bio-Technology/NNP General/NNP Corp./NNP received/VBD tenders/NNS for/IN #.#/CD %/NN of/IN its/PRP$ #.#/CD %/NN convertible/JJ senior/JJ subordinated/VBN notes/NNS due/JJ April/NNP #/CD ,/, #/CD ,/, and/CC #/CD %/NN of/IN its/PRP$ #/CD %/NN convertible/JJ senior/JJ subordinated/VBN debentures/NNS due/JJ March/NNP #/CD ,/, #/CD ./.
In/IN exchange/NN offers/NNS that/WDT expired/VBD Friday/NNP ,/, holders/NNS of/IN each/DT $/$ #,#/CD of/IN notes/NNS will/MD receive/VB $/$ #/CD face/NN amount/NN of/IN Series/NNP A/NNP #.#/CD %/NN senior/JJ secured/VBN convertible/JJ notes/NNS due/JJ Jan./NNP #/CD ,/, #/CD ,/, and/CC #/CD common/JJ shares/NNS ./.
For/IN each/DT $/$ #,#/CD face/NN amount/NN of/IN debentures/NNS ,/, holders/NNS received/VBD $/$ #/CD of/IN Series/NNP B/NNP #/CD %/NN senior/JJ secured/VBN convertible/JJ notes/NNS due/JJ Oct./NNP #/CD ,/, #/CD ,/, and/CC #/CD common/JJ shares/NNS ./.
Bio-Technology/NNP ,/, a/DT New/NNP York/NNP maker/NN of/IN genetically/RB engineered/VBN products/NNS for/IN human/NN and/CC animal/NN health/NN care/NN ,/, said/VBD it/PRP made/VBD the/DT exchange/NN offer/NN to/TO reduce/VB its/PRP$ interest/NN payments/NNS ./.
